Clinical Trials Sponsored by CureLab Oncology

Total 4559 results

CureLab Oncology

Active, not recruiting

Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer

Belarus
CureVac

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies

Belgium, Germany
CureVac

Completed

RNActive® Rabies Vaccine (CV7201) in Healthy Adults

Rabies

Germany
CureVac

Terminated

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

Prostate Cancer

France, Czech Republic, Germany, Poland, Spain, Sweden, Switzerland, United Kingdom
Aurolab

Unknown

Safety and Surgical Performance Study of Aurosleek Surgical Blades (Aurosleek)

Cataract

India
Aurolab

Unknown

Clinical Evaluation of Toric Intraocular Lens Made by Aurolab (TORICIOL)

Astigmatism

India
Aurolab

Unknown

Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma (AADI)

Glaucoma

India
Aurolab

Completed

Aurolab Hydrophobic Foldable Intraocular Lens Study

Cataract

India
CureVac

Active, not recruiting

Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

Glioblastoma

Belgium, Germany, Netherlands
CureVac

Completed

Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease

Hormonal Refractory Prostate Cancer

Germany, Italy
CureVac

Completed

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Switzerland, Germany
Aurolab

Unknown

Safety and Efficacy Study of Artificial Cornea (AuroKPro)

Corneal Transplantation

India
Aurolab

Unknown

Natural History of IOL in Pseudo Exfoliation Syndrome (PXF)

Pseudo Exfoliation Syndrome

India
Aurolab

Completed

Clinical Evaluation of a New Cartridge for the Implantation of Foldable Intraocular Lenses

Cataract

India
Aurolab

Unknown

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

Glaucoma

India
Aurolab

Completed

The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction (ACO)

Retinitis Pigmentosa | Cataract

India
Aurolab

Completed

Study of PGA Suture in Ophthalmology

Glaucoma

India
CureVac

Completed

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

Covid19 | SARS-CoV-2

Belgium, Spain, Germany, Argentina, Colombia, Dominican Republic, Mexico, Netherlands, Panama, Peru
CureVac

Terminated

COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Belgium
CureVac

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus
CureVac

Completed

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

Rabies

Germany
CureVac

Terminated

Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Carcinoma

Germany, Switzerland, Austria
CureVac

Terminated

An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

Prostate Carcinoma

Germany
Aurolab

Unknown

Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost

Ocular Hypertension | Glaucoma, Open-Angle

India
Aurolab

Completed

Efficacy of Aurosling in Frontalis Sling Suspension Surgery

Ptosis, Eyelid

India
Aurolab

Completed

Posterior Capsule Opacification Study

Cataract

India
Aurolab

Completed

The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora

Epiphora

India
GlaxoSmithKline
CureVac

Completed

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Influenza, Human

Belgium, Spain, Canada
GlaxoSmithKline
CureVac

Active, not recruiting

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

SARS-CoV-2

Australia, United States
GlaxoSmithKline
CureVac

Active, not recruiting

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Influenza, Human

United States, Belgium, South Africa, Canada
CureVac
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

Influenza

Panama
GlaxoSmithKline
CureVac

Completed

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

SARS-CoV-2

United States
Bayer
CureVac

Withdrawn

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (CV-NCOV-011)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection
University of Florida
CureVac

Terminated

RNActive®-Derived Therapeutic Vaccine

Hormone Refractory Prostate Cancer

United States
University Hospital, Clermont-Ferrand
Abbott; Corelab ISIT

Completed

Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT (RESTO)

In-stent Restenosis

France, Belgium, Switzerland
ReFlow Medical, Inc.
Massachusetts General Hospital; Syntropic Corelab

Completed

Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy. (DEEPER)

Critical Limb Ischemia

Dominican Republic
Hemoteq AG
CERES GmbH; coreLab Black Forest GmbH

Completed

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Claudication

Germany, Austria, France
CureVac
Syneos Health; Cromos Pharma LLC

Active, not recruiting

Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

Carcinoma, Adenoid Cystic | Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Carcinoma, Squamous Cell of Head and Neck

Spain, France, Austria, Germany, Russian Federation
CureVac
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus

Belgium, Germany
Mural Oncology, Inc
Immune Oncology Network

Completed

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Non-cutaneous Squamous Cell Carcinoma of Head and Neck

United States
Hirschfeld Oncology

Not yet recruiting

Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer (GFLIPM)

Pancreatic Cancer

United States
Ikena Oncology

Recruiting

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors

Solid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene Fusions

United States, United Kingdom
CivaTech Oncology

Recruiting

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Lung Cancer | Lung Cancer Stage I | Lung Cancer Stage II

United States
CivaTech Oncology

Recruiting

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Pancreatic Cancer

United States
Strata Oncology

Terminated

Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors (Sentinel)

Cancer

United States
Cardiff Oncology

Active, not recruiting

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

Metastatic Colorectal Cancer | Colorectal Cancer

United States
CivaTech Oncology

Completed

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

Cancer | Pancreas Cancer

United States
CivaTech Oncology

Completed

Linear Source Registry for Prostate Cancer (CaRePC)

Prostate Cancer

United States
Elevation Oncology

Active, not recruiting

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Sarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bladder Cancer | Metastatic Solid Tumor | Gallbladder Cancer | Uterine Cancer | Locally Advanced Solid Tumor

United States, Korea, Republic of, Australia, Canada
Que Oncology

Completed

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Vasomotor Symptoms (VMS)

3

Subscribe